TIL |
Instil Bio, Inc. |
79.89M |
3.59% |
|
|
|
|
|
12.18 |
-5.21% |
576.12% |
75.97% |
---|
REPL |
Replimune Group, Inc. |
752.82M |
3.54% |
|
|
|
|
|
9.78 |
-0.05% |
122.01% |
14.82% |
---|
IOVA |
Iovance Biotherapeutics, Inc. |
1.11B |
3.47% |
|
|
|
|
|
3.38 |
-5.99% |
130.38% |
48.84% |
---|
ZYME |
Zymeworks Inc. |
907.28M |
3.45% |
|
|
|
|
|
13.04 |
0.23% |
291.26% |
58.93% |
---|
ARGX |
argenx SE |
38.99B |
3.42% |
|
|
|
|
|
638.49 |
-1.03% |
31.77% |
32.51% |
---|
GMAB |
Genmab A/S |
13.06B |
3.42% |
|
|
|
|
|
20.94 |
-1.02% |
74.56% |
44.67% |
---|
AZN |
AstraZeneca PLC |
435.69B |
3.39% |
|
|
|
|
|
70.27 |
-2.12% |
34.59% |
53.90% |
---|
BMY |
Bristol-Myers Squibb Company |
101.08B |
3.39% |
|
|
|
|
|
49.67 |
-1.06% |
42.70% |
60.71% |
---|
CRSP |
CRISPR Therapeutics AG |
3.25B |
3.39% |
|
|
|
|
|
37.69 |
-2.55% |
66.84% |
64.32% |
---|
MRK |
Merck & Co., Inc. |
210.02B |
3.37% |
|
|
|
|
|
83.46 |
-2.04% |
41.05% |
63.29% |
---|
NKTR |
Nektar Therapeutics |
143.49M |
3.37% |
|
|
|
|
|
0.7710 |
-3.08% |
288.36% |
62.82% |
---|
XNCR |
Xencor, Inc. |
770.22M |
3.37% |
|
|
|
|
|
10.83 |
-1.77% |
81.40% |
44.47% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
62.34B |
3.36% |
|
|
|
|
|
582.91 |
-2.65% |
49.81% |
76.60% |
---|
FATE |
Fate Therapeutics, Inc. |
140.39M |
3.33% |
|
|
|
|
|
1.2250 |
-4.30% |
236.51% |
49.41% |
---|
GILD |
Gilead Sciences, Inc. |
129.85B |
3.33% |
|
|
|
|
|
104.16 |
-2.23% |
38.50% |
61.83% |
---|
RCUS |
Arcus Biosciences, Inc. |
898.96M |
3.32% |
|
|
|
|
|
8.49 |
-2.97% |
286.49% |
39.78% |
---|
ATRA |
Atara Biotherapeutics, Inc. |
46.55M |
3.30% |
|
|
|
|
|
7.81 |
-2.27% |
769.79% |
94.72% |
---|
ALLO |
Allogene Therapeutics, Inc. |
359.57M |
3.29% |
|
|
|
|
|
1.6550 |
-1.49% |
677.77% |
87.88% |
---|
RUBY |
Rubius Therapeutics, Inc. |
|
3.29% |
|
|
|
|
|
|
|
|
|
---|
TRIL |
Trillium Therapeutics Inc. |
|
3.29% |
|
|
|
|
|
|
|
|
|
---|
BLUE |
bluebird bio, Inc. |
40.38M |
3.28% |
|
|
|
|
|
4.13 |
1.10% |
122.15% |
11.34% |
---|
IBRX |
ImmunityBio, Inc. |
2.16B |
3.28% |
|
|
|
|
|
2.4450 |
-2.59% |
162.94% |
80.02% |
---|
IMAB |
I-Mab |
74.07M |
3.25% |
|
|
|
|
|
0.9089 |
-3.31% |
546.25% |
N/A |
---|
IGMS |
IGM Biosciences, Inc. |
79.20M |
3.23% |
|
|
|
|
|
1.3250 |
-4.33% |
187.84% |
100.00% |
---|
STTK |
Shattuck Labs, Inc. |
49.82M |
3.23% |
|
|
|
|
|
1.0400 |
5.16% |
586.39% |
69.64% |
---|
ALXO |
ALX Oncology Holdings Inc. |
27.90M |
3.21% |
|
|
|
|
|
0.5226 |
-3.22% |
270.19% |
41.68% |
---|
LEGN |
Legend Biotech Corporation |
3.15B |
3.20% |
|
|
|
|
|
34.34 |
-1.75% |
65.05% |
22.04% |
---|
BGNE |
BeiGene, Ltd. |
|
3.19% |
|
|
|
|
|
|
|
|
|
---|
MGNX |
MacroGenics, Inc. |
106.62M |
3.17% |
|
|
|
|
|
1.6900 |
-2.59% |
120.94% |
50.24% |
---|
YMAB |
Y-mAbs Therapeutics, Inc. |
184.49M |
3.12% |
|
|
|
|
|
4.08 |
-4.00% |
299.13% |
61.45% |
---|
Cash&Other |
|
|
0.13% |
|
|
|
|
|
|
|
|
|
---|